Press Releases Hikma Pharmaceuticals PLC

Equities

HIK

GB00B0LCW083

Market Closed - London S.E. Other stock markets 11:35:15 2024-05-02 am EDT			5-day change	1st Jan Change
1,925 ^GBX	-0.52%		+5.83%	+7.60%

Apr. 26	HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets
Apr. 25	Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hikma Pharmaceuticals : Special Business passed at AGM	Apr. 25	PU
Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business	Apr. 16	AQ
Hikma launches Fentanyl Citrate Injection, USP, in a prefilled syringe in the US	Feb. 21	AQ
Hikma Pharmaceuticals PLC - Notice of preliminary results	Feb. 06	AQ
Activ Surgical, a Hikma Ventures portfolio company, completes the first international procedure using ActivSight Intelligent Light at Abdali Hospital in Jordan	Jan. 24	AQ
Activ Surgical Announces Completion of First International Procedure Using Its ActivSight Intelligent Light	Jan. 23	AQ
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa	Jan. 08	BU
Hikma launches Phenylephrine HCl Injection, USP, in ready-to-use vials in the US	Dec. 20	AQ
Hikma continues strong momentum across the Group and upgrades guidance for 2023	Nov. 03	AQ
Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa	23-10-11	AQ
Hikma marks two-year anniversary of KLOXXADO launch by surpassing 375,000 doses donated in the US	23-10-04	AQ
Hikma and SK Biopharmaceuticals enter a strategic partnership for the Middle East and North Africa	23-08-21	AQ
Hikma remains a constituent of the FTSE4Good Index	23-08-16	AQ
Hikma and Rakuten Medical sign exclusive licensing agreement for Alluminox platform cancer treatment for the Middle East and North Africa	23-08-11	AQ
Hikma appoints new President of Injectables business	23-08-10	AQ
Hikma Ventures invests in Octave Bioscience, a precision care platform for Multiple Sclerosis and other neurodegenerative diseases	23-07-27	AQ
Octave Bioscience Closes $30M Extension to Series B Funding	23-07-27	AQ
Hikma Pharmaceuticals PLC - Notice of results	23-07-18	AQ
Hikma launches Midazolam in 0.9% Sodium Chloride Injection in the US	23-07-03	AQ
Hikma launches Neostigmine Methylsulfate Injection, USP in prefilled syringe	23-06-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets

April 26, 2024 at 06:50 am EDT